Abstract
Combination therapy of OK432 and recombinant human interferon alpha A/D on viral myocarditis in mice starting after infection.
T Yokoyama, T Kanda, T Suzuki and K Murata
Journal of Pharmacology and Experimental Therapeutics September 1991, 258 (3) 1114-1119;